{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:19:20Z","timestamp":1761585560967,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006109","name":"Scientific Grant Agency","doi-asserted-by":"publisher","award":["VEGA 2\/0029\/16","VEGA 2\/0115\/19","VEGA 2\/0124\/19"],"award-info":[{"award-number":["VEGA 2\/0029\/16","VEGA 2\/0115\/19","VEGA 2\/0124\/19"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Slovak Research and Development Agency","doi-asserted-by":"publisher","award":["APVV-15-0308"],"award-info":[{"award-number":["APVV-15-0308"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.intimp.2019.02.015","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T06:10:51Z","timestamp":1550211051000},"page":"368-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Novel aspects of the activation of NADPH oxidase in neutrophils of rheumatic patients on biological therapy"],"prefix":"10.1016","volume":"69","author":[{"given":"Viera","family":"Jan\u010dinov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katar\u00edna","family":"Dr\u00e1bikov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdenko","family":"Killinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Pa\u017eourekov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radom\u00edr","family":"Nos\u00e1\u013e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juraj","family":"Payer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2019.02.015_bb0005","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molmed.2016.01.005","article-title":"Novel immunotherapeutic avenues for rheumatoid arthritis","volume":"22","author":"Semerano","year":"2016","journal-title":"Trends Mol. Med."},{"issue":"47","key":"10.1016\/j.intimp.2019.02.015_bb0010","article-title":"PD-L1-expressing neutrophils as a novel indicator to assess disease activity and severity of systemic lupus erythematosus","volume":"18","author":"Luo","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2019.02.015_bb0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.smim.2016.03.004","article-title":"Human neutrophils in auto-immunity","volume":"28","author":"Thieblemont","year":"2016","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2019.02.015_bb0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-3083.2011.02503.x","article-title":"Neutrophils of rheumatoid arthritis patients on anti-TNF-\u03b1 therapy and in disease remission present reduced adhesive functions in association with decreased circulating neutrophil-attractant chemokine levels","volume":"73","author":"Dominical","year":"2011","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2019.02.015_bb0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pathophys.2005.07.006","article-title":"Neutrophil gene expression in rheumatoid arthritis","volume":"12","author":"Cross","year":"2005","journal-title":"Pathophysiology"},{"key":"10.1016\/j.intimp.2019.02.015_bb0030","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/rheumatology\/keq045","article-title":"Neutrophil function in inflammation and inflammatory diseases","volume":"49","author":"Wright","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.intimp.2019.02.015_bb0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2249.2008.03634.x","article-title":"Redox signalling and the inflammatory response in rheumatoid arthritis","volume":"152","author":"Filippin","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2019.02.015_bb0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.intimp.2019.02.015_bb0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11515-012-1250-y","article-title":"The role of NADPH oxidase (NOX) enzymes in neurodegenerative disease","volume":"8","author":"Ajayi","year":"2013","journal-title":"Front. Biol."},{"key":"10.1016\/j.intimp.2019.02.015_bb0050","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.freeradbiomed.2010.09.016","article-title":"Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for?","volume":"49","author":"Bylund","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.intimp.2019.02.015_bb0055","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.yexcr.2012.12.020","article-title":"Inhibition of phospholipase A2 abrogates intracellular processing of NADPH-oxidase derived reactive oxygen species in human neutrophils","volume":"319","author":"Bj\u00f6rnsdottir","year":"2013","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.intimp.2019.02.015_bb0060","first-page":"922","article-title":"Toll-like receptor 3 and interleukin 1\u03b2 expression in CD34+ cells from patients with rheumatoid arthritis: association with inflammation and vascular involvement","volume":"32","author":"Lo Gullo","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2019.02.015_bb0065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3109\/03009742.2013.836564","article-title":"Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress","volume":"43","author":"Lo Gullo","year":"2014","journal-title":"Scand. J. Rheumatol."},{"issue":"5","key":"10.1016\/j.intimp.2019.02.015_bb0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.it.2009.03.004","article-title":"The protective role of ROS in autoimmune disease","volume":"30","author":"Hultqvist","year":"2009","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2019.02.015_bb0075","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1002\/art.23941","article-title":"Phagocyte-derived reactive oxygen species as suppressors of inflammatory disease","volume":"58","author":"Bjorkman","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.intimp.2019.02.015_bb0080","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1089\/ars.2007.1569","article-title":"Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategies","volume":"9","author":"Gelderman","year":"2007","journal-title":"Antioxid. Redox Signal."},{"issue":"10","key":"10.1016\/j.intimp.2019.02.015_bb0085","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1002\/art.23942","article-title":"Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype","volume":"58","author":"Fergusson","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"16","key":"10.1016\/j.intimp.2019.02.015_bb0090","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1089\/ars.2013.5828","article-title":"Reactive oxygen species deficiency induced autoimmunity with type 1 interferon signature","volume":"21","author":"Kelkka","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2019.02.015_bb0095","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/imr.12378","article-title":"Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation","volume":"269","author":"Holmdahl","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2019.02.015_bb0100","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.imbio.2004.09.008","article-title":"Blockade of TNF does not alter oxygen burst and phagocytosis of human neutrophils in patients with rheumatoid arthritis","volume":"209","author":"Hartmann","year":"2005","journal-title":"Immunobiology"},{"key":"10.1016\/j.intimp.2019.02.015_bb0105","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/1756-185X.12582","article-title":"Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio","volume":"18","author":"Uslu","year":"2015","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.intimp.2019.02.015_bb0110","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1159\/000447948","article-title":"Hematological indices may be useful in the diagnosis of systemic lupus erythematosus and in determining disease activity in Behcet's disease","volume":"25","author":"Yolbas","year":"2016","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.intimp.2019.02.015_bb0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.intimp.2015.05.048","article-title":"Selective inhibition of extracellular oxidants liberated from human neutrophils \u2013 a new mechanism potentially involved in the anti-inflammatory activity of hydroxychloroquine","volume":"28","author":"Jan\u010dinov\u00e1","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2019.02.015_bb0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1179\/135100006X116592","article-title":"The combined luminol\/isoluminol chemiluminescence method for differentiating between extracellular and intracellular oxidant production by neutrophils","volume":"11","author":"Jan\u010dinov\u00e1","year":"2006","journal-title":"Redox Rep."},{"key":"10.1016\/j.intimp.2019.02.015_bb0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-59745-467-4_23","article-title":"Measurements of respiratory burst products generated by professional phagocytes","volume":"412","author":"Dahlgren","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.intimp.2019.02.015_bb0130","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0891-5849(97)00326-2","article-title":"One- and two-electron oxidations of luminol by peroxidase systems","volume":"24","author":"Nakamura","year":"1998","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2019.02.015_bb0135","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000443177","article-title":"Equol effectively inhibits toxic activity of human neutrophils without influencing their viability","volume":"97","author":"Pa\u017eourekov\u00e1","year":"2016","journal-title":"Pharmacology"},{"key":"10.1016\/j.intimp.2019.02.015_bb0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1515\/intox-2017-0009","article-title":"Pharmacological intervention with oxidative burst in human neutrophils","volume":"10","author":"Nos\u00e1\u013e","year":"2017","journal-title":"Interdiscip. Toxicol."},{"key":"10.1016\/j.intimp.2019.02.015_bb0145","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3904\/kjim.2015.137","article-title":"Current concepts in the management of rheumatoid arthritis","volume":"31","author":"Tanaka","year":"2016","journal-title":"Korean J. Intern. Med."},{"issue":"4","key":"10.1016\/j.intimp.2019.02.015_bb0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00018-009-0205-1","article-title":"Platelets and innate immunity","volume":"67","author":"Semple","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2019.02.015_bb0155","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nrrheum.2012.118","article-title":"Platelets: active players in the pathogenesis of arthritis and SLE","volume":"8","author":"Boilard","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2019.02.015_bb0160","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3526460","article-title":"Diagnostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in Crohn's disease","volume":"2017","author":"Feng","year":"2017","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.intimp.2019.02.015_bb0165","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/429878","article-title":"Fc\u03b3 and complement receptors and complement proteins in neutrophil activation in rheumatoid arthritis: contribution to pathogenesis and progression and modulation by natural products","volume":"2015","author":"Paoliello-Paschoalato","year":"2015","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.intimp.2019.02.015_bb0170","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.autrev.2009.12.013","article-title":"Neutrophils in rheumatoid arthritis: more than simple final effectors","volume":"9","author":"Cascao","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2019.02.015_bb0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bbrc.2010.02.071","article-title":"Antioxidants: molecules, medicines, and myths","volume":"393","author":"Gutteridge","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.intimp.2019.02.015_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030348","article-title":"A new arthritis therapy with oxidative burst inducers","volume":"3","author":"Hultqvist","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.intimp.2019.02.015_bb0185","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7007-5-19","article-title":"Arthritis suppression by NADPH activation operates through an interferon-\u03b2 pathway","volume":"5","author":"Olofsson","year":"2007","journal-title":"BMC Biol."},{"key":"10.1016\/j.intimp.2019.02.015_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2349817","article-title":"Neutrophil-mediated regulation of innate and adaptive immunity: the role of myeloperoxidase","volume":"2016","author":"Odobasic","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2019.02.015_bb0195","doi-asserted-by":"crossref","first-page":"R250","DOI":"10.1186\/ar1477","article-title":"Effect of adalimumab on neutrophil functions in patients with rheumatoid arthritis","volume":"7","author":"Capsoni","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2019.02.015_bb0200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/clim.2001.5183","article-title":"Immune functions in patients with rheumatoid arthritis treated with etanercept","volume":"103","author":"Moreland","year":"2002","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2019.02.015_bb0205","first-page":"232","article-title":"Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-\u03b1 monoclonal antibody in patients with rheumatoid arthritis","volume":"30","author":"Den Broeder","year":"2003","journal-title":"J. Rheumatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918312931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918312931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:11:26Z","timestamp":1761585086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918312931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":41,"alternative-id":["S1567576918312931"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.02.015","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel aspects of the activation of NADPH oxidase in neutrophils of rheumatic patients on biological therapy","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}